tacrolimus

The medicine is used to control the immune system response after an organ transplant (e.g., liver, kidney, heart) to prevent organ rejection. It may also be used when the organ rejection process is already underway or when previous treatment has not been effective.

Form: capsules, hard

ATC: L04AA05

Manufacturer: Lek Pharmaceuticals d.d.

The medicine is used to control the immune system response after an organ transplant (e.g., liver, kidney, heart) to prevent rejection. It may also be used when the organ rejection process is already underway or when previous treatment has not been effective.

Form: capsules, hard

ATC: L04AA05

Manufacturer: Lek Pharmaceuticals d.d.

Cidimus is used to control the immune system response after an organ transplant (e.g., liver, kidney, heart) to prevent organ rejection. It may also be used when the process of organ rejection is already underway or when previous treatment has not been effective.

Form: capsules, hard

ATC: L04AA05

Manufacturer: Lek Pharmaceuticals d.d.

The medicine is used in adult patients to control the immune system response after an organ transplant (e.g., liver or kidney) to prevent rejection. It may also be used when the process of transplant rejection is already underway and previous treatment has not been effective.

Form: capsules, extended release, hard

ATC: L04AD02

Manufacturer: Lek Pharmaceuticals d.d.

The medicine is used in adult patients to control the immune system response after an organ transplant (e.g., liver or kidney) to prevent rejection. It can also be used when the organ rejection process (e.g., liver, kidney, or heart) is already underway and previous treatment has not been effective.

Form: capsules, extended release, hard

ATC: L04AD02

Manufacturer: Lek Pharmaceuticals d.d.

Dailiport is used in adult patients to control the immune system response after an organ transplant (e.g., liver or kidney) to prevent rejection. It may also be used when the process of transplant rejection (liver, kidney, heart, or others) is ongoing and previous treatment has not been effective.

Form: capsules, extended release, hard

ATC: L04AD02

Manufacturer: Lek Pharmaceuticals d.d.

Dailiport is used in adults to control the immune system response after an organ transplant (e.g., liver or kidney) to prevent rejection. It may also be used when the rejection process of a transplanted organ (liver, kidney, heart, or others) is ongoing and previous treatment has not been effective.

Form: capsules, extended release, hard

ATC: L04AD02

Manufacturer: Lek Pharmaceuticals d.d.

The medicine is used in adult patients to control the immune system response after an organ transplant (e.g., liver or kidney) to prevent rejection. It can also be used when the process of organ rejection (liver, kidney, heart, or others) is already occurring and previous treatment has not been effective.

Form: capsules, extended release, hard

ATC: L04AD02

Manufacturer: Lek Pharmaceuticals d.d.

It is used in the treatment of moderate to severe atopic dermatitis (eczema) in adults for whom other treatment methods have not been effective or were poorly tolerated. It helps to relieve inflammation, itching, redness, and skin dryness.

Form: ointment

ATC: D11AH01

Manufacturer: Bausch Health Poland Sp. z o.o. Laboratori Fundació Dau

The medicine is used to control the immune system response after organ transplantation (e.g., liver, kidney, or heart) to prevent rejection. It may also be used in cases of transplanted organ rejection or when previous treatment has not been effective.

Form: solution for infusion, concentrate

ATC: L04AD02

Manufacturer: Astellas Ireland Co., Ltd.

The medicine is used to control the immune system response after organ transplantation (e.g., liver, kidney, or heart) to prevent rejection. It may also be used in cases of transplanted organ rejection or when previous treatment has not been effective.

Form: capsules, hard

ATC: L04AD02

Manufacturer: Astellas Ireland Co., Ltd.

The medicine is used to control the immune system response after organ transplantation (e.g., liver, kidney, or heart) to prevent rejection. It may also be used when previous treatment has not been effective or when there is a risk of rejection of the transplanted organ.

Form: capsules

ATC: L04AD02

Manufacturer: Astellas Ireland Co., Ltd.

The medicine is used to control the immune system response after organ transplantation (e.g., liver, kidney, or heart) to prevent rejection. It may also be used when previous treatment has not been effective or in cases of risk of transplanted organ rejection.

Form: capsules, hard

ATC: L04AD02

Manufacturer: Astellas Ireland Co., Ltd.

The medicine is used in adult patients to control the immune system response after organ transplantation (e.g., liver or kidney) to prevent rejection. It may also be used in the event of transplant rejection if other treatments have not been effective.

Form: capsules, extended release, hard

ATC: L04AD02

Manufacturer: Centrafarm Services B.V. Pharmathen International S.A. Pharmathen S.A. STADA Arzneimittel AG

The medicine is used in adult patients to control the immune system response after organ transplantation (e.g., liver or kidney) to prevent rejection. It may also be used in cases of rejection of a transplanted liver, kidney, heart, or other organs if previous treatment has not been effective.

Form: capsules, extended release, hard

ATC: L04AD02

Manufacturer: Centrafarm Services B.V. Pharmathen International S.A. Pharmathen S.A. STADA Arzneimittel AG

The medicine is used in adult patients to control the immune system response after organ transplantation (e.g., liver or kidney) to prevent rejection. It may also be used in the event of rejection of a transplanted organ if other treatments have not been effective.

Form: capsules, extended release, hard

ATC: L04AD02

Manufacturer: Centrafarm Services B.V. Pharmathen International S.A. Pharmathen S.A. STADA Arzneimittel AG

The medicinal product is used in adult patients to control the immune response after organ transplantation (e.g., liver or kidney) to prevent rejection. It may also be used in cases of rejection of a transplanted liver, kidney, heart, or other organs if other treatments have not been effective.

Form: capsules, extended release, hard

ATC: L04AD02

Manufacturer: Centrafarm Services B.V. Pharmathen International S.A. Pharmathen S.A. STADA Arzneimittel AG